Geschäftskunden Kundenprogramme

KI-Beratung Beta
Vor Ort
Merkzettel Warenkorb
Produktbild: Fdg-Pet/CT vs. Non-Fdg Tracers in Less Explored Domains, an Issue of Pet Clinics
Band 17

Fdg-Pet/CT vs. Non-Fdg Tracers in Less Explored Domains, an Issue of Pet Clinics Volume 17-3

Aus der Reihe The Clinics: Internal Medicine

Fr. 109.00

inkl. gesetzl. MwSt., Versandkostenfrei

Beschreibung

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

21.06.2022

Herausgeber

Sandip Basu + weitere

Verlag

Elsevier Health Science

Seitenzahl

240

Maße (L/B/H)

18.6/26.3/2 cm

Gewicht

4500 g

Sprache

Englisch

ISBN

978-0-323-89718-1

Beschreibung

Portrait

Rakesh Kumar acquired qualifications of Environment Science and Engineering from IIT Bombay in 1987. He then pursued work on developing technologies for automobile pollution control, which also led to a Ph.D.in Environment Engineering. Dr. Kumar's experience includes a wide range of environment science and engineering field, such as: Air Pollution Control and Management, Water and Wastewater Treatment, Hazardous & Municipal Waste Management, Environmental Impact Assessment and Environmental Audit and Climate Change.

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

21.06.2022

Herausgeber

Verlag

Elsevier Health Science

Seitenzahl

240

Maße (L/B/H)

18.6/26.3/2 cm

Gewicht

4500 g

Sprache

Englisch

ISBN

978-0-323-89718-1

EU-Ansprechpartner

Elsevier B.V.
Radarweg 29
1043 NX Amsterdam
NL
productsafety@elsevier.com

Herstelleradresse

Elsevier Health Science
London Wall 125
EC2Y 5AS London
GB
tradeorders@elsevier.com

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)
  • Produktbild: Fdg-Pet/CT vs. Non-Fdg Tracers in Less Explored Domains, an Issue of Pet Clinics

  • Facts and Fictions About [18F]FDG versus Other Tracers in Managing Patients with Brain Tumors: It Is Time to Rectify the Ongoing Misconceptions
    An Appraisal and Update of Fluorodeoxyglucose and Non-Fluorodeoxyglucose-PET Tracers in Thyroid and Non-Thyroid Endocrine Neoplasms
    18F-Fluorodeoxyglucose-PET-Computerized Tomography and non-Fluorodeoxyglucose PET-Computerized Tomography in Hepatobiliary and Pancreatic Malignancies
    Molecular Imaging Assessment of Androgen Deprivation Therapy in Prostate Cancer
    Molecular Imaging Assessment of Hormonally Sensitive Breast Cancer: An Appraisal of 2- [18F]-Fluoro-2-Deoxy-Glucose and Newer Non-2-[18F]-Fluoro-2-Deoxy-Glucose PET Tracers18F-FDG Versus Non-FDG PET Tracers in Multiple Myeloma
    Role of Molecular Imaging with PET/MR Imaging in the Diagnosis and Management of Brain Tumors
    Fibroblast Activation Protein Inhibitor Theranostics
    PET-CT Based Quantitative Parameters for Assessment of Treatment Response and Disease Activity in Cancer and Noncancerous Disorders
    Positron Emission Tomography-Based Assessment of Cognitive Impairment and Dementias, Critical Role of Fluorodeoxyglucose in such Settings
    >fluorodeoxyglucose PET/Computed Tomography Applications
    Fluorodeoxyglucose PET/Computed Tomography in Evaluation of Prosthetic Joints and Diabetic Foot: A Comparative Perspective with Other Functional Imaging Modalities
    Utility of PET/Computed Tomography in Infection and Inflammation Imaging
    Role of Fluorodeoxyglucose-PET in Interventional Radiology